Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Journal of Pharmacy Practice|June 21, 2021
Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell DiseaseSalome Bwayo Weaver, Dhakrit Rungkitwattanakul, Divita SinghThe Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|March 25, 2024
Roles of Pharmacists in the Management of Sickle Cell Disease in Adults: A Narrative ReviewSalome Bwayo Weaver, Nkem P Nonyel, Dhakrit RungkitwattanakulPharmacy (Basel, Switzerland)|June 23, 2022
Kidney Function Assessment in African American Patients: A Narrative Review for PharmacistsDhakrit Rungkitwattanakul, Weerachai Chaijamorn, Eunice Han, et al.Critical Care Explorations|June 28, 2023
Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication ShortageMohammed Aldhaeefi, Abdulrahman Alshaya, Sanaa Belrhiti, et al.Pharmacy (Basel, Switzerland)|July 27, 2022
Creating a Machine Learning Tool to Predict Acute Kidney Injury in African American Hospitalized PatientsSasha Pierre-Paul, Xiang S Wang, Constance Mere, et al.Journal of Pharmacy Practice|September 19, 2022
Rates of Opioid Misuse Amongst Patients Receiving Pain Management for Sickle Cell Disease in An Urban SettingNadia Ahmed, Nkemjika Okany, Divita Singh, et al.Journal of Critical Care|September 19, 2020
Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapyWeerachai Chaijamorn, Dhakrit Rungkitwattanakul, Sutthiporn Pattharachayakul, et al.Journal of Chemotherapy (Florence, Italy)|August 23, 2021
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenemDhakrit Rungkitwattanakul, Amy L Ives, Nicole G Harriott, et al.Journal of Intensive Care|November 10, 2023
Lacosamide dosing in patients receiving continuous renal replacement therapyWeerachai Chaijamorn, Sathian Phunpon, Thanompong Sathienluckana, et al.International Journal of Clinical Pharmacology and Therapeutics|September 1, 2025
Empagliflozin and hydralazine-isosorbide dinitrate combination therapy improves outcomes in black patients with heart failurePadmamalini Baskaran, Mohammed Aldhaeefi, Anahita Asaadi, et al.Pageof 3